OBJECTIVE: Outcome investigations of prenatal maternal depression and psychotropic exposure rely extensively on maternal retrospective recall. This study compared postnatal recall to prospective documentation of illness and medication exposures. DESIGN: Prospective cohort and retrospective case-control studies. SETTING: Emory Women's Mental Health Program (prospective study) and Emory University Department of Psychology (retrospective study). SAMPLE: A total of 164 women who participated in both the prospective and retrospective studies. METHODS: Women with a history of mental illness were followed during pregnancy for prospective prenatal assessments of depression and medication exposures. At 6 months postpartum, some of these women also participated in a retrospective study during which they were asked to recall prenatal depression and medication use. Agreement between prospective and retrospective documentation of exposures was analysed. MAIN OUTCOME MEASURES: Occurrence of maternal depression during pregnancy and maternal use of pharmacological agents during pregnancy. RESULTS: There was only moderate agreement (k = 0.42) in prospective versus retrospective reporting of prenatal depression. Positive predictive value for recalling depression was 90.4%; however, negative predictive value for denying depression was only 53.8%. Participants accurately recalled psychotropic use but significantly underreported use of nonpsychotropic medications. CONCLUSIONS: Studies using retrospective data collection may be susceptible to systematic recall bias with underreporting of maternal depression and use of nonpsychotropic agents during pregnancy.
OBJECTIVE: Outcome investigations of prenatal maternal depression and psychotropic exposure rely extensively on maternal retrospective recall. This study compared postnatal recall to prospective documentation of illness and medication exposures. DESIGN: Prospective cohort and retrospective case-control studies. SETTING: Emory Women's Mental Health Program (prospective study) and Emory University Department of Psychology (retrospective study). SAMPLE: A total of 164 women who participated in both the prospective and retrospective studies. METHODS:Women with a history of mental illness were followed during pregnancy for prospective prenatal assessments of depression and medication exposures. At 6 months postpartum, some of these women also participated in a retrospective study during which they were asked to recall prenatal depression and medication use. Agreement between prospective and retrospective documentation of exposures was analysed. MAIN OUTCOME MEASURES: Occurrence of maternal depression during pregnancy and maternal use of pharmacological agents during pregnancy. RESULTS: There was only moderate agreement (k = 0.42) in prospective versus retrospective reporting of prenatal depression. Positive predictive value for recalling depression was 90.4%; however, negative predictive value for denying depression was only 53.8%. Participants accurately recalled psychotropic use but significantly underreported use of nonpsychotropic medications. CONCLUSIONS: Studies using retrospective data collection may be susceptible to systematic recall bias with underreporting of maternal depression and use of nonpsychotropic agents during pregnancy.
Authors: Carol Louik; Angela E Lin; Martha M Werler; Sonia Hernández-Díaz; Allen A Mitchell Journal: N Engl J Med Date: 2007-06-28 Impact factor: 91.245
Authors: I Nulman; J Rovet; D E Stewart; J Wolpin; H A Gardner; J G Theis; N Kulin; G Koren Journal: N Engl J Med Date: 1997-01-23 Impact factor: 91.245
Authors: Tim F Oberlander; Shaila Misri; Colleen E Fitzgerald; Xanthoula Kostaras; Dan Rurak; Wayne Riggs Journal: J Clin Psychiatry Date: 2004-02 Impact factor: 4.384
Authors: Victoria Hendrick; Lynne M Smith; Rita Suri; Sun Hwang; Desiree Haynes; Lori Altshuler Journal: Am J Obstet Gynecol Date: 2003-03 Impact factor: 8.661
Authors: Samuel J House; Shanti P Tripathi; Bettina T Knight; Natalie Morris; D Jeffrey Newport; Zachary N Stowe Journal: Arch Womens Ment Health Date: 2015-07-16 Impact factor: 3.633
Authors: Marleen M H J van Gelder; Iris A L M van Rooij; Hermien E K de Walle; Nel Roeleveld; Marian K Bakker Journal: Drug Saf Date: 2013-01 Impact factor: 5.606
Authors: Helen B Chin; Donna D Baird; D Robert McConnaughey; Clarice R Weinberg; Allen J Wilcox; Anne Marie Jukic Journal: Epidemiology Date: 2017-07 Impact factor: 4.822
Authors: Wayne J Katon; Joan E Russo; Jennifer L Melville; Jodie G Katon; Amelia R Gavin Journal: Gen Hosp Psychiatry Date: 2011-11-03 Impact factor: 3.238
Authors: Jodie G Katon; Joan Russo; Amelia R Gavin; Jennifer L Melville; Wayne J Katon Journal: J Womens Health (Larchmt) Date: 2011-06-13 Impact factor: 2.681